Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Ebner

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|March 7, 2006
Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platformDavid Bol, Reinhard Ebner
Drug Discovery Today. Disease Mechanisms|November 26, 2008
EditorialReinhard Ebner, Thomas Ried
International Journal of Radiation Biology|December 7, 2007
Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?Juergen Friedrich, Reinhard Ebner, Leoni A Kunz-Schughart
Nature Protocols|February 14, 2009
Spheroid-based drug screen: considerations and practical approachJuergen Friedrich, Claudia Seidel, Reinhard Ebner, et al.
Journal of Biomolecular Screening|June 12, 2004
The use of 3-D cultures for high-throughput screening: the multicellular spheroid modelLeoni A Kunz-Schughart, James P Freyer, Ferdinand Hofstaedter, et al.
Pharmacogenomics|December 16, 2005
Expression biomarkers for clinical efficacy and outcome prediction in cancerKathryn J Strand, Hanif Khalak, Jeffrey W Strovel, et al.
Cancers|October 1, 2014
STAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyMelanie Spitzner, Reinhard Ebner, Hendrik A Wolff, et al.
Journal of Biomolecular Screening|October 19, 2007
A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assayJuergen Friedrich, Wolfgang Eder, Juana Castaneda, et al.
Cancer Research|April 3, 2004
Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinomaMichael A Rieger, Reinhard Ebner, David R Bell, et al.
Oncology Reports|December 8, 2004
Highly specific overexpression of the transcription factor SOX11 in human malignant gliomasBernd Weigle, Reinhard Ebner, Achim Temme, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|March 7, 2006
Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platformDavid Bol, Reinhard Ebner
Drug Discovery Today. Disease Mechanisms|November 26, 2008
EditorialReinhard Ebner, Thomas Ried
International Journal of Radiation Biology|December 7, 2007
Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?Juergen Friedrich, Reinhard Ebner, Leoni A Kunz-Schughart
Nature Protocols|February 14, 2009
Spheroid-based drug screen: considerations and practical approachJuergen Friedrich, Claudia Seidel, Reinhard Ebner, et al.
Journal of Biomolecular Screening|June 12, 2004
The use of 3-D cultures for high-throughput screening: the multicellular spheroid modelLeoni A Kunz-Schughart, James P Freyer, Ferdinand Hofstaedter, et al.
Pharmacogenomics|December 16, 2005
Expression biomarkers for clinical efficacy and outcome prediction in cancerKathryn J Strand, Hanif Khalak, Jeffrey W Strovel, et al.
Cancers|October 1, 2014
STAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyMelanie Spitzner, Reinhard Ebner, Hendrik A Wolff, et al.
Journal of Biomolecular Screening|October 19, 2007
A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assayJuergen Friedrich, Wolfgang Eder, Juana Castaneda, et al.
Cancer Research|April 3, 2004
Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinomaMichael A Rieger, Reinhard Ebner, David R Bell, et al.
Oncology Reports|December 8, 2004
Highly specific overexpression of the transcription factor SOX11 in human malignant gliomasBernd Weigle, Reinhard Ebner, Achim Temme, et al.
Pageof 2